SNW1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.906400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.989200E-01
Normal-vs-Stage2
8.813400E-01
Normal-vs-Stage3
3.458000E-01
Normal-vs-Stage4
2.834800E-01
Stage1-vs-Stage2
5.068800E-01
Stage1-vs-Stage3
4.340400E-01
Stage1-vs-Stage4
4.651600E-02
Stage2-vs-Stage3
1.404990E-01
Stage2-vs-Stage4
1.049600E-01
Stage3-vs-Stage4
9.338400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.348200E-01
Normal-vs-AfricanAmerican
4.744600E-01
Normal-vs-Asian
4.447600E-01
Caucasian-vs-AfricanAmerican
3.333200E-01
Caucasian-vs-Asian
1.225000E-01
AfricanAmerican-vs-Asian
8.759400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.463800E-01
Normal-vs-Female
8.188400E-01
Male-vs-Female
5.395800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.168600E-01
Normal-vs-Age(41-60Yrs)
7.166600E-01
Normal-vs-Age(61-80Yrs)
7.145400E-01
Normal-vs-Age(81-100Yrs)
9.869200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.298200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.813600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.677600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.410310E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.120400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.591400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.248800E-01
Normal-vs-Daily Drinker
8.517800E-01
Normal-vs-Weekly Drinker
6.228600E-01
Normal-vs-Occasional Drinker
5.438200E-01
Normal-vs-Social Drinker
7.234600E-01
Non Drinker-vs-Daily Drinker
3.715400E-01
Non Drinker-vs-Weekly Drinker
9.406600E-01
Non Drinker-vs-Occasional Drinker
1.736430E-02
Non Drinker-vs-Social Drinker
5.122600E-01
Daily Drinker-vs-Weekly Drinker
4.793000E-01
Daily Drinker-vs-Occasional Drinker
1.607800E-01
Daily Drinker-vs-Social Drinker
8.486400E-01
Weekly Drinker-vs-Occasional Drinker
7.291700E-02
Weekly Drinker-vs-Social Drinker
5.891400E-01
Occasional Drinker-vs-Social Drinker
9.882500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.865600E-01
Normal-vs-Grade 2
7.326200E-01
Normal-vs-Grade 3
6.791200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.971600E-01
Grade 1-vs-Grade 3
5.818000E-02
Grade 1-vs-Grade 4
7.865600E-01
Grade 2-vs-Grade 3
1.559220E-01
Grade 2-vs-Grade 4
7.326200E-01
Grade 3-vs-Grade 4
6.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.040600E-01
Normal-vs-NonDiabetic
8.314200E-01
Diabetic-vs-NonDiabetic
8.828600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.824580E-01
Normal-vs-NoPancreatitis
9.022200E-01
Pancreatitis-vs-NoPancreatitis
5.367600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.410200E-01
Normal-vs-N1
9.264600E-01
N0-vs-N1
7.769000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.651000E-01
Normal-vs-TP53-NonMutant
7.370600E-01
TP53-Mutant-vs-TP53-NonMutant
2.877400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
